Reported May 13, 2026 · Announced · Updated Sep 17, 2026
Sun Pharmaceutical Industries, Inc. recalls Aisling DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL due to Presence of glass particles
Sun Pharmaceutical Industries, Inc.
Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.What you should do
Stop using the product and follow the return or refund instructions in the firm's announcement.
What it looks like
Is this the product you have?
- DOXOrubicin Hydrochloride
- Liposome Injection 50mg/25 mL BrandAisling. Drugs
Why it was recalled
Presence of glass particles
The agency has not ranked the risk yet — treat the notice as a caution.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Sun Pharmaceutical Industries, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.